Flexible Phase I–II Design for Partially Ordered Regimens with Application to Therapeutic Cancer Vaccines
Author
Abstract
Suggested Citation
DOI: 10.1007/s12561-019-09245-3
Download full text from publisher
As the access to this document is restricted, you may want to search for a different version of it.
References listed on IDEAS
- Yin, Guosheng & Yuan, Ying, 2009. "Bayesian Model Averaging Continual Reassessment Method in Phase I Clinical Trials," Journal of the American Statistical Association, American Statistical Association, vol. 104(487), pages 954-968.
- Chunyan Cai & Ying Yuan & Yuan Ji, 2014. "A Bayesian dose finding design for oncology clinical trials of combinational biological agents," Journal of the Royal Statistical Society Series C, Royal Statistical Society, vol. 63(1), pages 159-173, January.
- John O'Quigley & Michael D. Hughes & Terry Fenton, 2001. "Dose-Finding Designs for HIV Studies," Biometrics, The International Biometric Society, vol. 57(4), pages 1018-1029, December.
Citations
Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
Cited by:
- Bo Huang & Naitee Ting, 2020. "Introduction to Special Issue on ‘Statistical Methods for Cancer Immunotherapy’," Statistics in Biosciences, Springer;International Chinese Statistical Association, vol. 12(2), pages 79-82, July.
Most related items
These are the items that most often cite the same works as this one and are cited by the same works as this one.- Sean M. Devlin & Alexia Iasonos & John O’Quigley, 2021. "Phase I clinical trials in adoptive T‐cell therapies," Journal of the Royal Statistical Society Series C, Royal Statistical Society, vol. 70(4), pages 815-834, August.
- Thomas M. Braun, 2018. "Motivating sample sizes in adaptive Phase I trials via Bayesian posterior credible intervals," Biometrics, The International Biometric Society, vol. 74(3), pages 1065-1071, September.
- Patricia Gilholm & Kerrie Mengersen & Helen Thompson, 2020. "Identifying latent subgroups of children with developmental delay using Bayesian sequential updating and Dirichlet process mixture modelling," PLOS ONE, Public Library of Science, vol. 15(6), pages 1-17, June.
- Yimei Li & Ying Yuan, 2020. "PA‐CRM: A continuous reassessment method for pediatric phase I oncology trials with concurrent adult trials," Biometrics, The International Biometric Society, vol. 76(4), pages 1364-1373, December.
- B. Nebiyou Bekele & Yu Shen, 2005. "A Bayesian Approach to Jointly Modeling Toxicity and Biomarker Expression in a Phase I/II Dose-Finding Trial," Biometrics, The International Biometric Society, vol. 61(2), pages 343-354, June.
- José L. Jiménez & Mourad Tighiouart, 2022. "Combining cytotoxic agents with continuous dose levels in seamless phase I‐II clinical trials," Journal of the Royal Statistical Society Series C, Royal Statistical Society, vol. 71(5), pages 1996-2013, November.
- Yuxi Tao & Junlin Liu & Zhihui Li & Jinguan Lin & Tao Lu & Fangrong Yan, 2013. "Dose-Finding Based on Bivariate Efficacy-Toxicity Outcome Using Archimedean Copula," PLOS ONE, Public Library of Science, vol. 8(11), pages 1-6, November.
- Jin Zhang & Thomas M. Braun, 2013. "A Phase I Bayesian Adaptive Design to Simultaneously Optimize Dose and Schedule Assignments Both Between and Within Patients," Journal of the American Statistical Association, Taylor & Francis Journals, vol. 108(503), pages 892-901, September.
- Jiajing Xu & Guosheng Yin & David Ohlssen & Frank Bretz, 2016. "Bayesian two-stage dose finding for cytostatic agents via model adaptation," Journal of the Royal Statistical Society Series C, Royal Statistical Society, vol. 65(3), pages 465-482, April.
- Haitao Pan & Cailin Zhu & Feng Zhang & Ying Yuan & Shemin Zhang & Wenhong Zhang & Chanjuan Li & Ling Wang & Jielai Xia, 2014. "The Continual Reassessment Method for Multiple Toxicity Grades: A Bayesian Model Selection Approach," PLOS ONE, Public Library of Science, vol. 9(5), pages 1-8, May.
- Beibei Guo & Elizabeth Garrett‐Mayer & Suyu Liu, 2021. "A Bayesian phase I/II design for cancer clinical trials combining an immunotherapeutic agent with a chemotherapeutic agent," Journal of the Royal Statistical Society Series C, Royal Statistical Society, vol. 70(5), pages 1210-1229, November.
- Steven B Kim & Dong Sub Kim & Christina Magana-Ramirez, 2021. "Applications of statistical experimental designs to improve statistical inference in weed management," PLOS ONE, Public Library of Science, vol. 16(9), pages 1-21, September.
More about this item
Keywords
Adaptive design; Bayesian method; Immuno-oncology; Optimal biologic regimen; Phase I–II;All these keywords.
Statistics
Access and download statisticsCorrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:spr:stabio:v:12:y:2020:i:2:d:10.1007_s12561-019-09245-3. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.springer.com .
Please note that corrections may take a couple of weeks to filter through the various RePEc services.